| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |